Trial intelligence / Profile preview

Varenicline Nasal Spray for Dry Eye Disease in Japanese Adults

jRCT2051250028Completed

Sponsor
Viatris
Start
May 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in dry eye syndrome (DED) comparing OC-01 varenicline nasal spray with Placebo nasal spray (2 arms). Primary endpoint: Mean change from baseline in Tear Film Break-up Time (TBUT) at Week 4 (Day 29). Started May 2025; status: completed.

02

Drugs

varenicline
03

Conditions

dry eye syndrome (DED)

Beyond the preview

Go deeper on jRCT2051250028.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2051250028.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call